Home › Funds › Strategic Wealth Investment Group, LLC › BSX
Strategic Wealth Investment Group, LLC position in BSX
BOSTON SCIENTIFIC CORP · Health Care
Strategic Wealth Investment Group, LLC reported holding 207,211 shares of BSX (BOSTON SCIENTIFIC CORP) in its Q3 2026 13F filing — a position valued at US$9.0M, representing 1.12% of its reported portfolio and ranking #36 among its reported holdings. Strategic Wealth Investment Group, LLC has disclosed BSX holdings in 10 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-10-29 · Source: SEC EDGAR Form 13F-HR
How Strategic Wealth Investment Group, LLC's BSX position evolved
Strategic Wealth Investment Group, LLC first disclosed a stake in BSX in Q3 2023 at 4,431 shares (US$234K). The position peaked in Q3 2025 at 132,940 shares, worth US$13.0M. Across 10 filings, Strategic Wealth Investment Group, LLC increased the stake 3 time(s), trimmed it 5 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 207,211 shares valued at US$9.0M — a reduction of -2,404 shares quarter over quarter.. Notable position changes include a 46% trim in Q4 2024 (shares rose 13% over the following quarter), a 80% increase in Q2 2026 (shares rose 2% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 4.43K | $233.96K | New |
| Q4 2023 | 4.55K | $262.98K | Add |
| Q2 2024 | 4.46K | $341.02K | Reduce |
| Q3 2024 | 4.35K | $366.09K | Reduce |
| Q4 2024 | 2.33K | $208.03K | Reduce |
| Q3 2025 | 132.94K | $12.98M | New |
| Q4 2025 | 101.68K | $9.70M | Reduce |
| Q1 2026 | 116.61K | $7.32M | Add |
| Q2 2026 | 209.62K | $8.95M | Add |
| Q3 2026 | 207.21K | $9.04M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About BSX and 13F data
BSX (BOSTON SCIENTIFIC CORP) is a Health Care company. 20 other funds we track also report a position in BSX — the largest reported positions include Banque Cantonale Vaudoise (US$2.89B), PRIMECAP MANAGEMENT CO/CA/ (US$2.16B), D. E. Shaw & Co (US$1.16B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding BSX
- Banque Cantonale Vaudoise 67.61K sh · $2.89B · Q2 2026
- PRIMECAP MANAGEMENT CO/CA/ 50.52M sh · $2.16B · Q2 2026
- D. E. Shaw & Co 27.27M sh · $1.16B · Q2 2026
- Janus Henderson Group 16.50M sh · $1.04B · Q1 2026
- Arrowstreet Capital 23.29M sh · $994.18M · Q2 2026
- Bollard Group LLC 18.42M sh · $786.20M · Q2 2026
More on Strategic Wealth Investment Group, LLC
FAQ
How long has Strategic Wealth Investment Group, LLC held BSX?
Strategic Wealth Investment Group, LLC has disclosed BSX holdings in 10 of the last 13 reported quarters, going back to Q3 2023.
What is Strategic Wealth Investment Group, LLC's current position in BSX?
As of Q3 2026, Strategic Wealth Investment Group, LLC holds 207.21K shares of BSX (BOSTON SCIENTIFIC CORP), valued at $9.04M, representing 1.12% of its reported portfolio and ranking #36.
Has Strategic Wealth Investment Group, LLC been buying or selling BSX?
In the latest 13F filing (Q3 2026), Strategic Wealth Investment Group, LLC reduced its position in BSX. The position peaked in Q3 2025 at 132.94K shares.
Which other funds hold BSX?
Other major institutional holders of BSX include Banque Cantonale Vaudoise, PRIMECAP MANAGEMENT CO/CA/, D. E. Shaw & Co, among 20 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.